| Variables |
Groups |
|
| All (n=10) |
Astrocytoma (n=6) |
Medulloblastoma(n=6) |
Comparison of Variables’ Distribution among Groups |
| Gender (male/female) |
3/7 |
2/4 |
2/4 |
p=0,986 |
| Age at diagnosis |
2-7; average=4.1 |
3-10; average=6.1 |
2-11;average=6.8 |
p=0,251 |
| Age in the evaluation |
6-12; average=8.9 |
7-11; average=9 |
8-14; average=10.3 |
p=0,51 |
| Treatment |
Systemic Chemotherapy + Intrathecal Chemotherapy
(GBTLI-99 Protocol) |
Surgery |
Surgery, Chemotherapy and Cranial and neuroaxis radiotherapy
(Parker Protocol) |
NA |
| Drugs used in chemotherapy |
Methotrexate, Cytarabine Dexamethasone
Prednisone
Vincristine
L-asparagine
Daunorubicin
Cyclophosphamide
6-Mercaptopurine
Cytarabine
Doxorubicin
Thioguanine |
NA |
Vincristine
Cisplatin
Carmustine |
NA |
| Dosage of Radiotherapy |
NA |
NA |
36 Gy at the skull and neuroaxis + 18 Gytumor bed=54 Gy |
NA |
